Influence of the at 2 receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia

Journal of Human Hypertension

Volumn 27, Issue 6, 2013, Pages 355-361

  Gonzalez Garrido Chem J A ^a   Olivares Corichi, I M ^b   Tovar Rodriguez, J M ^c   Hernandez Santana N A ^b   Mendez Bolaina E ^a   Ceballos Reyes, G M ^b   Garcia Sanchez J R ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

angiotensin receptor; arginase; NADPH oxidase; preeclampsia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ARGINASE; ARGININE; CAVEOLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPICATECHIN; NITRATE; NITRIC OXIDE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ADULT; ARTICLE; COMPARATIVE STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREECLAMPSIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; ARGININE; CATECHIN; CELLS, CULTURED; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 2; YOUNG ADULT;

EID: 84877589240     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.55     Document Type: Article

References (33)

1. Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular development and function. Placenta 2011; 32: 797-805.
2. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol 2011; 31: 33-46.
3. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 2012; 5: 9-18.
4. Teran E, Escudero C, Moya W. Abnormal release of nitric oxide from nitrosoprotein in preeclampsia. Int J Gynaecol Obstet 2006; 92: 260-261.
5. Bagnost T, Berthelot A, Bouhaddi M, Laurant P, Andre C, Guillaume Y et al. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. J Hypertens 2008; 26: 1110-1118.
6. Ash DE. Structure and function of arginases. J Nutr 2004; 134: 2760S-2764S, discussion 2765S-2767S..
7. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003; 108: 2000-2006.
8. Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, Sikka G et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 2008; 102: 923-932.
9. Demougeot C, Prigent-Tessier A, Marie C, Berthelot A. Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. J Hypertens 2005; 23: 971-978.
10. Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004; 43: 614-622.
11. Sankaralingam S, Xu H, Davidge ST. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc Res 2010; 85: 194-203.
12. Cui XL, Brockman D, Campos B, Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 2006; 27: 422-431.
13. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003; 107: 1632-1639.
14. Redman CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003; 24: S21-S27.
15. Xia Y, Wen H, Bobst S, Day MC, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Invest 2003; 10: 82-93.
16. Corraliza IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994; 174: 231-235.
17. Jaffe EA (ed).Culture and identification of large vessel endothelial cells. in Biology of Endothelial Cells. pp 1-13 (Martinus Nijhoff: Boston, 1984).
18. Aleman I, Alex R, Ramirez M, Hung A, Ramirez C. Endothelial and inducible nitric oxide synthase expression in Venezuelan patients with pre-eclampsia. Invest Clin 2008; 49(3): 321-330.
19. Baksu B, Davas I, Baksu A, Akyol A, Gulbaba G. Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women. Int J Gynaecol Obstet 2005; 90(2): 112-117.
20. Teran E, Escudero C, Vivero S, Enriquez A, Calle A. Intraplatelet cyclic guanosine- 30,50-monophosphate levels during pregnancy and preeclampsia. Hypertens Pregnancy 2004; 23(3): 303-308.
21. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M et al. Diabetes- induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008; 102: 95-102.
22. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007; 27: 1269-1275.
23. Zhang W, Baban B, Rojas M, Tofigh S, Virmani SK, Patel C et al. Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. Am J Pathol 2009; 175: 891-902.
24. Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension 2009; 53: 270-277.
25. Matsubara K, Matsubara Y, Hyodo S, Katayama T. Ito M Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J Obstet Gynaecol Res 2010; 36(2): 239-247.
26. Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress markers and antioxidant levels in normal pregnancy and preeclampsia. Int J Gynaecol Obstet 2006; 94(1): 23-27.
27. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122(4): 369-382.
28. Chen GF, Wagner L, Sasser JM, Zharikov S, Moningka NC, Baylis C. Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats. Nephrol Dialysis Transplant 2010; 25: 3518-3525.
29. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82-C97.
30. Carey RM. Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 2005; 45: 840-844.
31. Carey RM, Padia SH. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab 2008; 19: 84-87.
32. Akbar SA, Khawaja NP, Brown PR, Tayyeb R, Bamfo J, Nicolaides KH. Angiotensin II type 1 and 2 receptors gene polymorphisms in preeclampsia and normal pregnancy in three different populations. Acta Obstet Gynecol Scand 2009; 23: 1-6.
33. Shatanawi A, Romero MJ, Iddings JA, Chandra S, Umapathy NS, Verin AD et al. Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. Am J Physiol Cell Physiol 2011; 300: C1181-C1192.